NASDAQ: VCEL · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Vericel Corporation

How Vericel Corporation compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.2B

Price

$42.91

P/E

90.7

EPS (TTM)

$0.47

1-year return

23.0%

Dividend yield

0.0%

52-week range

$37.85–$43.04

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources